Health Care: Drugs

Nivalis Therapeutics Inc (NVLS: NASDAQ)

$8.59 -0.01 | -0.12%
11/25/15 - 04:00 PM ET
Company Balance Sheet
Dec 2014
Cash and Equivalents 27.81M
Receivables 0.00
Inventories 0.00
Other Current Assets 0.00
Total Current Assets 28.44M
Property, Plant & Equipment, Gross 1.49M
Accumulated Depreciation & Depletion 1.40M
Property, Plant & Equipment, Net 91.36K
Intangibles 0.00
Other Non-Current Assets 10.00K
Total Non-Current Assets 101.36K
Liabilities & Shareholder Equity
Total Assets 28.54M
Accounts Payable 928.94K
Short Term Debt 0.00
Other Current Liabilities 0.00
Total Current Liabilities 2.42M
Long Term Debt 0.00
Deferred Income Taxes 0.00
Other Non-Current Liabilities 0.00
Minority Interest 0.00
Total Non-Current Liabilities 41.88M
Total Liabilities 44.30M
Preferred Stock Equity 0.00
Common Stock Equity -15.75M
Common Par 2.21K
Additional Paid In Capital 110.26M
Cumulative Translation Adjustment 0.00
Retained Earnings -126.02M
Treasury Stock 0.00
Other Equity Adjustments 0.00
Total Capitalization -15.75M
Total Equity -15.75M
Total Liabilities & Stock Equity 28.54M
Total Common Shares Outstanding 13.41M
Preferred Shares 0.00
Treasury Shares 0.00
Basic Weighted Shares Outstanding 7.64M
Diluted Weighted Shares Outstanding 7.64M
Number of Employees NA
Number of Part-Time Employees NA

Portfolios with NVLS

Latest NVLS Headlines from TheStreet

More Financial News for NVLS

Press Releases for NVLS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter